STOCK TITAN

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024

Hoth Therapeutics, Inc. (HOTH) will have its CEO attend the EF Hutton Annual Global Conference in New York, NY.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Hoth Therapeutics, Inc. (HOTH) will have its CEO attend the EF Hutton Annual Global Conference in New York, NY. The conference provides networking opportunities and a platform to showcase the company's biopharmaceutical endeavors.

Loading...
Loading translation...
Argus Session date unavailable
-2.06% session move Open Argus
Details

News Market Reaction – HOTH

The recorded move for HOTH in the trading session of this news was -2.06%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, May 1, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the EF Hutton Annual Global Conference in New York, NY. 

To learn more about the EF Hutton Annual Global Conference please visit https://efhutton.com/conference/.

About Hoth Therapeutics, Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate therapeutics that hold immense potential to create breakthroughs and diversify treatment options. To learn more, please visit https://ir.hoththerapeutics.com/ .

Investor Contact:
LR Advisors LLC 
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-to-attend-ef-hutton-annual-global-conference-may-15-2024-302132803.html

SOURCE Hoth Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the EF Hutton Annual Global Conference?

The EF Hutton Annual Global Conference is scheduled for May 15, 2024.

Who will attend the EF Hutton Annual Global Conference on behalf of Hoth Therapeutics?

Robb Knie, the Chief Executive Officer of Hoth Therapeutics, will be attending the EF Hutton Annual Global Conference.

Where is the EF Hutton Annual Global Conference taking place?

The conference will be held in New York, NY.

What is the purpose of Hoth Therapeutics attending the EF Hutton Annual Global Conference?

The attendance aims to provide networking opportunities and showcase the company's biopharmaceutical initiatives.

How can I learn more about the EF Hutton Annual Global Conference?

To learn more about the conference, visit https://efhutton.com/conference/.

Keep reading